FindTrial
Sign In

A retrospective study analyzing the correlation between creatinine/cystatin C ratio and 1-year mortality in breast cancer patients

A retrospective study analyzing the correlation between creatinine/cystatin C ratio and 1-year mortality in breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094785
Enrollment
Unknown
Registered
2024-12-27
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Q2:Creatinine/cystatin C Ratio
Q3:Creatinine/cystatin C Ratio
Q4:Creatinine/cystatin C Ratio
Q1:Creatinine/cystatin C Ratio

Sponsors

Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.postoperative pathological type of breast cancer of all pathological subtypes; 3.clinical stage of breast cancer I-IV; 4.all undergoing standardized anti-tumor therapy after diagnosis of breast cancer;

Exclusion criteria

Exclusion criteria: 1.severe decline in renal function (eGFR =300 mg/day; 2.lack of serum Cr or CysC levels within the same day; 3.patients with incomplete clinicopathologic data and loss of visits;

Design outcomes

Primary

MeasureTime frame
One-year Mortality Rate in Breast Cancer Patients;Creatinine/cystatin C ratio in breast cancer patients during treatment;—

Countries

China

Contacts

Public ContactLilixia

Affiliated Hospital of Guangdong Medical University

lisalady@126.com+86 18320311316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026